California Public Employees Retirement System Sells 236 Shares of Novanta Inc. (NASDAQ:NOVT)

California Public Employees Retirement System lessened its stake in shares of Novanta Inc. (NASDAQ:NOVTGet Rating) by 0.3% during the second quarter, Holdings Channel.com reports. The fund owned 77,702 shares of the technology company’s stock after selling 236 shares during the period. California Public Employees Retirement System’s holdings in Novanta were worth $9,423,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Meeder Asset Management Inc. bought a new position in shares of Novanta in the 1st quarter valued at $25,000. Aaron Wealth Advisors LLC bought a new position in shares of Novanta in the 1st quarter valued at $77,000. Lazard Asset Management LLC increased its stake in shares of Novanta by 23.1% in the 1st quarter. Lazard Asset Management LLC now owns 976 shares of the technology company’s stock valued at $138,000 after purchasing an additional 183 shares during the last quarter. Captrust Financial Advisors increased its stake in shares of Novanta by 227.3% in the 1st quarter. Captrust Financial Advisors now owns 1,545 shares of the technology company’s stock valued at $220,000 after purchasing an additional 1,073 shares during the last quarter. Finally, TownSquare Capital LLC bought a new position in shares of Novanta in the 2nd quarter valued at $224,000. Institutional investors own 99.96% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on NOVT. StockNews.com began coverage on Novanta in a research note on Wednesday, October 12th. They issued a “hold” rating on the stock. TheStreet raised Novanta from a “c+” rating to a “b-” rating in a report on Friday, August 5th.

Insider Activity at Novanta

In related news, CEO Matthijs Glastra sold 20,000 shares of the firm’s stock in a transaction on Tuesday, November 15th. The stock was sold at an average price of $160.06, for a total transaction of $3,201,200.00. Following the sale, the chief executive officer now owns 86,558 shares of the company’s stock, valued at approximately $13,854,473.48. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Novanta news, Director Thomas N. Secor sold 550 shares of Novanta stock in a transaction dated Monday, October 24th. The stock was sold at an average price of $125.00, for a total transaction of $68,750.00. Following the transaction, the director now directly owns 1,655 shares of the company’s stock, valued at approximately $206,875. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Matthijs Glastra sold 20,000 shares of Novanta stock in a transaction dated Tuesday, November 15th. The stock was sold at an average price of $160.06, for a total value of $3,201,200.00. Following the transaction, the chief executive officer now directly owns 86,558 shares in the company, valued at $13,854,473.48. The disclosure for this sale can be found here. Insiders have sold a total of 31,578 shares of company stock valued at $4,847,210 in the last 90 days. 1.40% of the stock is owned by corporate insiders.

Novanta Trading Up 1.8 %

NASDAQ NOVT opened at $157.75 on Wednesday. The company has a quick ratio of 1.55, a current ratio of 2.58 and a debt-to-equity ratio of 0.81. Novanta Inc. has a twelve month low of $110.84 and a twelve month high of $177.50. The company has a market cap of $5.63 billion, a price-to-earnings ratio of 77.71 and a beta of 1.26. The business’s fifty day moving average is $131.63 and its 200 day moving average is $131.67.

Novanta Profile

(Get Rating)

Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.

Featured Articles

Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVTGet Rating).

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.